Next Article in Journal
Can Growth of Nannochloropsis oculata under Modulated Stress Enhance Its Lipid-Associated Biological Properties?
Next Article in Special Issue
Marine-Derived Natural Product HDYL-GQQ-495 Targets P62 to Inhibit Autophagy
Previous Article in Journal
Acute Toxicity by Oral Co-Exposure to Palytoxin and Okadaic Acid in Mice
Previous Article in Special Issue
Anti-Inflammatory Polyketide Derivatives from the Sponge-Derived Fungus Pestalotiopsis sp. SWMU-WZ04-2
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical Constituents of the Deep-Sea-Derived Penicillium citreonigrum MCCC 3A00169 and Their Antiproliferative Effects

1
Center for Molecular Metabolism, School of Environmental and Biological Engineering, Nanjing University of Science and Technology, 200 Xiaolingwei Street, Nanjing 210094, China
2
Key Laboratory of Marine Genetic Resources, Third Institute of Oceanography, Ministry of Natural Resources, 184 Daxue Road, Xiamen 361005, China
3
Xiamen Key Laboratory of Marine Medicinal Natural Products Resources, Xiamen Medica College, 1999 Guankouzhong Road, Xiamen 361023, China
4
School of Pharmaceutical Sciences, Xiamen University, South Xiangan Road, Xiamen 361102, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2022, 20(12), 736; https://doi.org/10.3390/md20120736
Submission received: 21 October 2022 / Revised: 14 November 2022 / Accepted: 20 November 2022 / Published: 24 November 2022
(This article belongs to the Special Issue Bioactive Compounds from the Deep-Sea-Derived Microorganisms)

Abstract

:
Six new citreoviridins (citreoviridins J–O, 16) and twenty-two known compounds (728) were isolated from the deep-sea-derived Penicillium citreonigrum MCCC 3A00169. The structures of the new compounds were determined by spectroscopic methods, including the HRESIMS, NMR, ECD calculations, and dimolybdenum tetraacetate-induced CD (ICD) experiments. Citreoviridins J−O (16) are diastereomers of 6,7-epoxycitreoviridin with different chiral centers at C-2–C-7. Pyrenocine A (7), terrein (14), and citreoviridin (20) significantly induced apoptosis for HeLa cells with IC50 values of 5.4 μM, 11.3 μM, and 0.7 μM, respectively. To be specific, pyrenocine A could induce S phase arrest, while terrein and citreoviridin could obviously induce G0-G1 phase arrest. Citreoviridin could inhibit mTOR activity in HeLa cells.

Graphical Abstract

1. Introduction

Penicillium citreonigrum is a commonly found fungus known for its contamination of rice with citreoviridin (CTV), a yellow mycotoxin related to the disease of acute cardiac beriberi [1]. In addition to CTV, P. citreonigrum can also produce other structurally diverse compounds, including azaphilones [2], chromones [3], alkaloids [3,4,5], sesquiterpenes [6,7], meroterpenes [2], etc. Most of these compounds showed cytotoxicity against different tumor cells. For example, 2-hydroxyl-3-pyrenocine-thio propanoic acid, a sulfur-containing polyketone isolated from a deep-sea-derived P. citreonigrum XT20-134, showed a potent effect against Bel-7402 tumor cells with an IC50 value of 7.6 μM [5]; sclerotioramine, a chlorinated alkaloid obtained from the terrestrial P. citreonigrum, exhibited moderate activity against the HepG2 cell line with an IC50 value of 7.3 μg/mL [3].
Due to their ability to produce new secondary metabolites, deep-sea-derived microorganisms have attracted more and more attention [8]. As part of our continuous investigations on deep-sea-derived fungi [9,10,11], P. citreonigrum MCCC 3A00169 was subjected for a systematic chemical study. Consequently, 6 new CTVs (citreoviridins J−O, 16, Figure 1) and 22 known compounds (728, Figure S1) were obtained. We report herein the fermentation, isolation, structure, and bioactivities of these secondary metabolites.

2. Results and Discussion

The EtOAc extract of the fermentation broth of P. citreonigrum MCCC 3A00169 was subjected to extensive column chromatography (CC) over silica gel, ODS, and Sephadex LH-20. Final purification by semi-preparative HPLC yielded compounds 128. By a comparison of the NMR and MS data with references, 22 previously reported components were identified as pyrenocine A (7) [12], cerebrosides A (8) [13], ergosterol (9) [14], β-sitosterol (10) [15], dehydrololiolide (11) [16], 3-hydroxy-4-methoxycinnamic acid (12) [17], terrein-d-glucoside (13) [18], terrein (14) [18], microsphaerone B (15) [19], surfactin C15 (16) [20], butyrolactone V (17) [21], microsphaerone A (18) [19], butyrolactone I (19) [22], citreoviridin (20) [23], isocitreoviridin (21) [24], (+)-cyclopenol (22) [25], tryptamine (23) [26], 1H-indole-3-carboxylic acid (24) [27], pyrenocine B (25) [28], citreo-γ-pyrone (26) [29], de-O-methyldiaporthin (27) [30], and 3,4-dihydro-3,4,8-trihydroxy-1(2H)-naphthalenon (28) [31].
Compound 1 was assigned a molecular formula C23H30O7 according to the protonated ion peak at m/z 419.2049 (calcd for C23H31O7, 419.2064) in its HR-ESI-MS spectrum (Figure S2), requiring nine double-bond equivalents. The 1H and 13C NMR spectroscopic data (Table 1 and Table 2, Figures S3 and S4) showed one methyl doublet and four methyl singlets, one methoxyl, ten methines (three oxygenated and seven olefinic carbons), and six quaternary carbons (three olefinic carbons and one carbonyl carbon). A close comparison of the NMR data for 1 with those of the citreoviridin I, a CTV isolated from a mangrove endophytic fungus Penicillium sp. BJR-P2 [32], indicated that they were structurally similar. Further analysis of their HR-ESI-MS data revealed that 1 was the dehydration product of citreoviridin I. The speculation was clearly evidenced by the HMBC correlations (Figure 2) from H3-21 (δH 1.35, s) to C-6 (δC 84.3)/C-7 (δC 77.2)/C-8 (δC 144.7), H-8 (δH 6.41, d, J = 15.2 Hz) to C-7 (δC 77.2), H-6 (δH 3.60, s) to C-8 (δC 144.7), and H3-20 (δH 1.23, s) to C-6 (δC 84.3).
The relative configuration of 1 was determined by coupling constants analysis and an NOESY experiment. E-configurations for three double bonds of ∆8,10,12 were identified on the basis of the large coupling constants of 3J8,9 (15.2 Hz), 3J10,11 (14.8 Hz), and 3J12,13 (15.2 Hz), respectively (Table 1). A cis relationship between H3-21 and H-6 was established for their distinct NOESY cross-peak (Figure 3). The relative configuration of the 2,3,5-trimethyl-tetrahydro-furan-3,4-diol in 1 was elucidated as 2S*,3S*,4R*,5S* according to the NOESY correlations of H-2 (δH 3.92, q, J = 6.4 Hz) with H3-19 (δH 1.29, s) and of H-4 with H3-19 and H-6.
To determine the absolute configurations at C-6 and C-7 in 1, ECD calculations of the optimized conformations of (6R,7R)-1 (1a) and (6S,7S)-1 (1b) were obtained at the B3LYP/6-31+G(d) level. The agreement between the calculated ECD spectrum of 1b and the experimental ECD spectrum (Figure 4A) suggested a 6S,7S-configuration for compound 1.
The absolute configuration of 2,3,5-trimethyl-tetrahydro-furan-3,4-diol residues was determined by a dimolybdenum tetraacetate [Mo2(OAc)4]-induced CD (ICD) experiment. Generally, 1, 2-diol compounds can react with Mo2(OAc)4 to form chiral complexes showing multiple Cotton effects in the range of 250–650 nm, of which the band near 310 nm is closely related to the absolute configuration of 1, 2-diol [33,34]. This method is also suitable for rigid cyclic 1, 2-diols [35,36]. In our experiments, the ICD spectrum of 1 exhibited a positive Cotton effect at 310 nm (Figure 5), suggesting a positive torsional angle for the O–C–C–O moiety. It was ascertained that the 3S,4R-form could maintain the favored conformation (Scheme 1). Therefore, the absolute configuration of 1 was determined as (2S,3S,4R,5S,6S,7S)-6,7-dihydro-6,7-epoxycitreoviridin and named citreoviridin J.
An analysis of the 1H and 13C NMR spectroscopic data (Table 1 and Table 2) and HR-ESI-MS data of compounds 26 revealed that they share the same planar structure of 1. However, minor differences in the 13C NMR chemical shift ranging from C-1 to C-7 indicated that 26 were diastereomers of 1 with different configurations in the 2,3,5-trimethyl-6-oxiranyl-tetrahydro-furan-3,4-diol residues.
Therefore, similar to 1, NOESY, ECD, and ICD experiments and coupling constants analysis were also employed to determine the absolute configurations of 26. The geometry at 8,10,12 double bonds in 26 was assigned as E based on the large coupling constants (ca 15 Hz). Likewise, the trans-configuration of epoxides and the cis-configuration for H-6 and H3-21 in 26 were assigned on the basis of the NOESY correlations of H-6 to H3-21 (Figure 3). The relative configurations of the 2,3,5-trimethyl-tetrahydro-furan-3,4-diol residues in 26 were also elucidated based on NOESY correlations, as shown in Figure 3. The ECD spectra of 2 and 5 showed positive Cotton effects at 215 nm and 373 nm and negative Cotton effects at 270 nm (Figure 4), which were in accordance with that of 1. Therefore, 6S,7S-configuration was assigned for 2 and 5. On the contrary, 6R,7R-configuration was assigned for 3, 4, and 6 because of the mirror-like ECD spectra (Figure 4). Similar to that of 1, the Mo2(OAc)4-induced CD spectra of 3 and 5 exhibited positive Cotton effects at 300–350 nm, indicating positive torsional angles for the O–C–C–O moieties (Figure 5). So, 3S,4R-configuration was defined for 3 and 5. The negative Cotton effects at 300–350 nm represented negative torsional angles for the O–C–C–O moieties, establishing 3R and 4S configurations of 2, 4, and 6 (Figure 5). On the basis of the above evidence, the absolute configurations of 26 were defined as (2R,3R,4S,5S,6S,7S), (2S,3S,4R,5S,6R,7R), (2S,3R,4S,5R,6R,7R), (2R,3S,4R,5R,6S,7S), and (2R,3R,4S,5S,6R,7R), respectively, and were named as citreoviridins K–O.
All isolates were tested for antiproliferative activity against HeLa tumor cells. Compounds 7, 14, and 20 exhibited significant effects, with IC50 values of 5.4 μM, 11.3 μM, and 0.7 μM, respectively (Figure 6A). To further detect the apoptosis activity of these three compounds, Hela cells were analyzed by western blotting after treatment with 7, 14, and 20 for 40 h. The cleavage of PARP protein, a sensitive apoptotic marker, was used to detect the apoptosis activity. As shown in Figure 6B, they all induced potent apoptosis. It was reported that 20 could inhibit human umbilical vein endothelial cells (HUVECs) proliferation [37]. Compound 7 showed cytotoxicity against several cancer cells, with IC50 values ranging from 2.6 to 12.9 μM. Terrein (14) displayed strong cytotoxicities against human breast cancer MCF-7 cells [38] and human lung cancer A549 cells [39]. Hence, our findings were consistent with those reported in previous experiments, though different cancer cell lines were evaluated.
To detect their effect on cell cycle progression, HeLa cells were treated with compounds 7, 14, and 20 for 16 h, stained with propidium iodide, and analyzed by flow cytometry. As shown in Figure 7, 7 could induce S phase arrest, while 14 and 20 could obviously induce G0-G1 phase arrest. Compound 20 also inhibited the proliferation of HUVECs that were arrested at the G0/G1 phase [37].
As is known to all, the mTOR is one of the most usually activated signaling pathways in cancer. The major downstream target of the mTOR is the ribosomal protein S6.
Previously, citreoviridin induces myocardial apoptosis through the PPAR-γ-mTORC2-mediated autophagic pathway [40]. Therefore, compound 20 detected the protein level of the phosphorylation of S6. As is shown in Figure 8, compound 20 was found to obviously inhibit p-S6, indicating that 20 could strongly inhibit the mTOR pathway. Therefore, compound 20 might induce apoptosis through mTOR inhibition.

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotations were recorded on an Anton Paar MCP 100 polarimeter. ECD spectra were recorded on a Chirascan spectropolarimeter. The HRESIMS spectra were recorded on Q-Exactive Focus tandem mass spectrometry. The NMR spectra were recorded on a Bruker AVANCE III 400 MHz spectrometer. The preparative and semipreparative HPLC were performed on an Agilent Technologies 1260 infinity instrument using ODS or Chiralpak IC columns. UV spectra were recorded on a UV-8000 UV/Vis spectrometer. Column chromatography (CC) was performed on silica gel and Sephadex LH-20. The TLC plates were visualized under UV light or by spraying with 10% H2SO4.

3.2. Biological Material

The fungal strain Penicillium citreonigrum was isolated from the deep-sea sediment of the Northeastern Pacific at a depth of −2530 m. The voucher strain was preserved at the Marine Culture Collection of China (MCCC, Xiamen, China) and was given the accession number MCCC 3A00169.

3.3. Fermentation and Extraction

P. citreonigrum MCCC 3A00169 was grown under static conditions at 25 °C in 85 × 1 L Erlenmeyer flasks, each containing 80 g of rice and 120 mL of distilled H2O. After 47 days, the fermentation broth was extracted by EtOAc three times to give a crude extract (32 g).

3.4. Isolation and Purification

The EtOAc-soluble extract was subjected to CC over silica gel using gradient CH2Cl2-MeOH to give six fractions (Fr.1−Fr.6). Fraction Fr.1 (7 g) was separated into three subfractions (Fr.1-1−Fr.1-3) by CC over ODS with MeOH-H2O (40%→100%). Fr.1-1 (31 mg) was further separated by HPLC (10%→40%→100%, MeOH-H2O) to yield 7 (22 mg, tR 32 min) and 11 (2 mg, tR 29 min). Fr.1-3 (0.7 g) was purified by CC over Sephadex LH-20 (MeOH) to yield 9 (5 mg) and 10 (54 mg). Fraction Fr.2 (0.9 g) was separated by Sephadex LH-20 (MeOH) to yield 12 (2 mg). Fraction Fr.3 (10.3 g) was purified by CC over ODS with MeOH-H2O (30%→100%) to yield eleven subfractions (Fr.3-1−Fr.3-11). Fr.3-1−Fr.3-6 was directly separated by Sephadex LH-20 (MeOH) to yield 14 (295 mg), 22 (10 mg), 23 (2 mg), 24 (2 mg), and 16 (694 mg), respectively. Fr.3-7 was further purified to CC over Sephadex LH-20 (MeOH) and HPLC (55%→80%, MeOH-H2O) to yield 17 (5 mg) and a mixture of 5 and 6, which was further isolated by the IC chiral column using n-hexane isopropyl alcohol (55%) as the mobile phase to yield 5 (2 mg, tR 25.6 min) and 6 (2 mg, tR 26.5 min). Fr.3-8 (877 mg) was purified by CC over Sephadex LH-20 (MeOH), HPLC (70%→85%, MeOH-H2O), and crystallization (MeOH) to afford compounds 15 (5 mg), 18 (3 mg), 20 (22 mg, tR 27.5 min), and 21 (5 mg, tR 28.7 min). Fr.3-9 was separated by Sephadex LH-20 (MeOH) and HPLC (10%→40%, MeOH-H2O) to yield 26 (3 mg, tR 33 min). Fr.3-10 was separated by Sephadex LH-20 (MeOH) and HPLC (52%→70%, MeOH-H2O) to yield 3 (2 mg, tR 34 min), 4 (4 mg, tR 31.5 min), 19 (11 mg), and 27 (3 mg). Fr.3-11 was separated by Sephadex LH-20 (MeOH) and HPLC (55%→70%, MeOH-H2O) to yield 1 (8 mg, tR 33.2 min), 2 (7 mg, tR 31.5 min), and 25 (4 mg). Fraction Fr.4 (0.9 g) was subjected to CC over ODS with MeOH-H2O (20%→100%) and CC on Sephadex LH-20 (MeOH) to yield 28 (3 mg). Fraction Fr.5 (1.2 g) was separated by CC over Sephadex LH-20 (MeOH) and HPLC (5%→20%, MeOH-H2O) to yield 8 (70 mg) and 13 (2 mg, tR 25 min).
Citreoviridin J (1): Yellow powder; [α ] D 20 − 10 (c 0.10, MeOH); ECD (MeOH) λmaxε) 372 (1.87), 271 (9.81), 216 (6.99) nm; UV (MeOH) λmax (log ε) 196 (3.52), 273 (4.30), 369 (4.31) nm; 1H and 13C NMR data, Table 1 and Table 2; HRESIMS m/z 419.2049 [M + H]+ (calcd for C23H31O7, 419.2064).
Citreoviridin K (2): Yellow powder; [α ] D 20 + 2 (c 0.10, MeOH); ECD (MeOH) λmaxε) 373 (1.13), 271 (2.88), 217 (2.54) nm; UV (MeOH) λmax (log ε) 196 (4.50), 274 (4.32), 369 (4.30) nm; 1H and 13C NMR data, Table 1 and Table 2; HRESIMS m/z 419.2063 [M + H]+ (calcd for C23H31O7, 419.2064).
Citreoviridin L (3): Yellow powder; [α ] D 20 − 113 (c 0.10, MeOH); ECD (MeOH) λmaxε) 362(3.40), 270 (9.35), 205 (6.88) nm; UV (MeOH) λmax (log ε) 197 (3.68), 273 (4.40), 367 (4.41) nm; 1H and 13C NMR data, Table 1 and Table 2; HRESIMS m/z 419.2056 [M + H]+ (calcd for C23H31O7, 419.2064).
Citreoviridin M (4): Yellow powder; [α ] D 20 + 20 (c 0.10, MeOH); ECD (MeOH) λmaxε) 370 (0.70), 272 (8.06), 216 (5.83) nm; UV (MeOH) λmax (log ε) 197 (3.67), 273 (4.45), 369 (4.43) nm; 1H and 13C NMR data, Table 1 and Table 2; HRESIMS m/z 419.2055 [M + H]+ (calcd for C23H31O7, 419.2064).
Citreoviridin N (5): Yellow powder; [α ] D 20 − 52 (c 0.10, MeOH); ECD (MeOH) λmaxε) 373 (0.58), 272 (−2.55), 231 (1.27) nm; UV (MeOH) λmax (log ε) 198 (3.67), 272 (4.41), 369 (4.33) nm; 1H and 13C NMR data, Table 1 and Table 2; HRESIMS m/z 419.2045 [M + H]+ (calcd for C23H31O7, 419.2064).
Citreoviridin O (6): Yellow powder; [α ] D 20 − 12 (c 0.10, MeOH); ECD (MeOH) λmaxε) 367 (−1.11), 274 (5.18), 211 (−4.03) nm; UV (MeOH) λmax (log ε) 197 (3.43), 274 (4.28), 368 (4.39) nm; 1H and 13C NMR data, Table 1 and Table 2; HRESIMS m/z 419.2042 [M + H]+ (calcd for C23H31O7, 419.2064).

3.5. ECD Calculation

The conformational analysis was first performed via random searching in the Stochastic using the MMFF94 force field with an energy cutoff of 7.0 kcal/mol and an RMSD threshold of 0.2 Å. All conformers were consecutively optimized at the PM6 and HF/6-31G(d) levels. Dominative conformers were re-optimized at the B3LYP/6-31G(d) level in the gas phase. The theoretical ECD spectra were calculated with the B3LYP method at the 6-311G(d,p) level in MeOH using Gaussian 09. The ECD spectrum was simulated by overlapping Gaussian functions for each transition [41].

3.6. Measurement of ICD Spectra

Compounds 16 were first dissolved in appropriate DMSO. Then, a quantity of Mo2(OAc)4 were added, with a ligand-to-metal ratio of approximately 1:1.2. The first CD spectrum (CD0) was recorded immediately after mixing and scanned every 10 min until a stationary CD spectrum (CD1) was measured. The induced CD (ICD) spectra were calculated from the CD of the ligand–metal complex (CD1) deducting the inherent CD (CD0).

3.7. The Antiproliferative Bioassay

As reported previously, the experiment was conduct using the Cell Counting Kit-8 (CCK-8) assay [42]. Briefly, HeLa cells were seeded in a 96-well plate at a density of 2000 cells/well and were cultured in MEM/EBSS (MEM) containing 10% FBS at 37 °C. After 24 h, the cells were treated with the test compounds, and incubation continued for 72 h. Then, 10 μL CCK-8 solution was added to each well. After incubation at 37 °C for 4 h, the absorbance value of each well was determined using a multi-well plate reader at 450 nm.

3.8. Flow Cytometry

After the indicated time treatment, cancer cell arrest was assessed by an FACScan flow cytometer (Beckman Coulter, California, USA), following the manual procedure. The cells were harvested by trypsin digestion, washed with PBS, and fixed with ice-cold 70% ethanol at 4 °C overnight. The fixed cells were then washed twice in PBS and treated for 30 min at RT with propidium iodide in PBS and analyzed. Flow cytometry data were analyzed using CytExpert (Beckman Coulter).

3.9. Western Blot Analysis

For Western blot assays, HeLa cells were treated with the compounds for the indicated time. Then, the cells were harvested, lysed, and centrifuged at 12,000 rpm/min for 10 min. The supernatant was added with a 1/5 volume of 5 × SDS and boiled. After electrophoresis, protein samples were transferred to the PVDF film, blocked with fat-free milk, incubated with the first antibody and washed, and then incubated with the secondary antibody and washed. Then, the ECL droplets were reacted on the membrane surface, and the bands were imaged by the multifunctional chemiluminescence imaging system.

4. Conclusions

From the deep-sea-derived Penicillium citreonigrum MCCC 3A00169, 6 new and 22 known compounds were obtained. Compounds 7, 14, and 20 significantly induced apoptosis against HeLa cells with IC50 values of 5.4 μM, 11.3 μM, and 0.7 μM.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md20120736/s1, Figure S1: Chemical structures of compounds 728; Figures S2–S54: The 1D-NMR, 2D-NMR, and HRMS spectra of compounds 16.

Author Contributions

J.-S.W., X.-W.Y. and X.-K.Z. designed and coordinated the project. Z.-B.Z., C.-L.X. and M.-M.X. isolated and purified all compounds. Y.-Q.Z. conducted the bioactive experiments. L.X. and Y.-J.H. performed the fermentation. Z.-B.Z., G.Z., L.-Z.L. and X.-W.Y. analyzed the data and wrote the paper, while critical revision of the publication was performed by all authors. All authors have read and agreed to the published version of the manuscript.

Funding

The work was supported by the National Natural Science Foundation of China (22177143 and 21877022) and the Science and Technology Research Program of Xiamen Medical College (KPT2020-03).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Uchiyama, Y.; Takino, M.; Noguchi, M.; Shiratori, N.; Kobayashi, N.; Sugita-Konishi, Y. The In vivo and in vitro toxicokinetics of citreoviridin extracted from Penicillium citreonigrum. Toxins 2019, 11, 360. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Wang, X.; Sena Filho, J.G.; Hoover, A.R.; King, J.B.; Ellis, T.K.; Powell, D.R.; Cichewicz, R.H. Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum. J. Nat. Prod. 2010, 73, 942–948. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Yuan, W.H.; Wei, Z.W.; Dai, P.; Wu, H.; Zhao, Y.X.; Zhang, M.M.; Jiang, N.; Zheng, W.F. Halogenated metabolites isolated from Penicillium citreonigrum. Chem. Biodivers. 2014, 11, 1078–1087. [Google Scholar] [CrossRef] [PubMed]
  4. Huang, J.N.; Zou, Q.B.; Chen, J.; Xu, S.H.; Luo, D.; Zhang, F.G.; Lu, Y.Y. Phenols and diketopiperazines isolated from antarctic-derived fungi, Penicillium citreonigrum SP-6. Phytochem. Lett. 2018, 27, 114–118. [Google Scholar] [CrossRef]
  5. Tang, X.X.; Liu, S.Z.; Yan, X.; Tang, B.W.; Fang, M.J.; Wang, X.M.; Wu, Z.; Qiu, Y.K. Two new cytotoxic compounds from a deep-sea Penicillum citreonigrum XT20-134. Mar. Drugs 2019, 17, 509. [Google Scholar] [CrossRef] [Green Version]
  6. Yuan, W.H.; Goto, M.; Hsieh, K.Y.; Yuan, B.; Zhao, Y.; Morris-Natschke, S.L.; Lee, K.H. Selective cytotoxic eremophilane-type sesquiterpenes from Penicillium citreonigrum. J. Asian Nat. Prod. Res. 2015, 17, 1239–1244. [Google Scholar] [CrossRef] [Green Version]
  7. Yuan, W.H.; Zhang, Y.; Zhang, P.; Ding, R.R. Antioxidant sesquiterpenes from Penicillium citreonigrum. Nat. Prod. Commun. 2017, 12, 1827–1829. [Google Scholar] [CrossRef] [Green Version]
  8. Sun, C.X.; Mudassir, S.; Zhang, Z.Z.; Feng, Y.Y.; Chang, Y.M.; Che, Q.; Gu, Q.Q.; Zhu, T.J.; Zhang, G.J.; Li, D.H. Secondary metabolites from deep-sea derived microorganisms. Curr. Med. Chem. 2020, 27, 6244–6273. [Google Scholar] [CrossRef]
  9. Xie, C.L.; Zhang, D.; Guo, K.Q.; Yan, Q.X.; Zou, Z.B.; He, Z.H.; Wu, Z.; Zhang, X.K.; Chen, H.F.; Yang, X.W. Meroterpenthiazole A, a unique meroterpenoid from the deep-sea-derived Penicillium allii-sativi, significantly inhibited retinoid X receptor (RXR)-α transcriptional effect. Chin. Chem. Lett. 2022, 33, 2057–2059. [Google Scholar] [CrossRef]
  10. Niu, S.; Xie, C.L.; Xia, J.M.; Liu, Q.M.; Peng, G.; Liu, G.M.; Yang, X.W. Botryotins A–H, tetracyclic diterpenoids representing three carbon skeletons from a deep-sea-derived Botryotinia fuckeliana. Org. Lett. 2020, 22, 580–583. [Google Scholar] [CrossRef]
  11. Niu, S.; Xia, J.M.; Li, Z.; Yang, L.H.; Yi, Z.W.; Xie, C.L.; Peng, G.; Luo, Z.H.; Shao, Z.; Yang, X.W. Aphidicolin chemistry of the deep-sea-derived fungus Botryotinia fuckeliana MCCC 3A00494. J. Nat. Prod. 2019, 82, 2307–2331. [Google Scholar] [CrossRef] [PubMed]
  12. Zhang, H.; Mao, L.L.; Qian, P.T.; Shan, W.G.; Wang, J.D.; Bai, H. Two new metabolites from a soil fungus Curvularia affinis strain HS-FG-196. J. Asian Nat. Prod. Res. 2012, 14, 1078–1083. [Google Scholar] [CrossRef] [PubMed]
  13. Koga, J.; Yamauchi, T.; Shimura, M.; Ogawa, N.; Oshima, K.; Umemura, K.; Kikuchi, M.; Ogasawara, N. Cerebrosides A and C, sphingolipid elicitors of hypersensitive cell death and phytoalexin accumulation in rice plants. J. Biol. Chem. 1998, 273, 31985–31991. [Google Scholar] [CrossRef] [Green Version]
  14. Guo, R.H.; Zhang, Y.T.; Duan, D.; Fu, Q.; Zhang, X.Y.; Yu, X.W.; Wang, S.J.; Bao, B.; Wu, W.H. Fibrinolytic evaluation of compounds isolated from a marine fungus Stachybotrys longispora FG216. Chin. J. Chem. 2016, 34, 1194–1198. [Google Scholar] [CrossRef]
  15. Zhao, D.; Zheng, L.; Qi, L.; Wang, S.; Guan, L.; Xia, Y.; Cai, J. Structural features and potent antidepressant effects of total sterols and beta-sitosterol extracted from Sargassum horneri. Mar. Drugs 2016, 14, 123. [Google Scholar] [CrossRef] [PubMed]
  16. Uegaki, R.; Fujimori, T.; Kaneko, H.; Kato, K.; Noguchi, M. Isolation of dehydrololiolide and 3-oxo-actinidol from Nicotiana tabacum. Agric. Biol. Chem. 1979, 43, 1149–1150. [Google Scholar] [CrossRef] [Green Version]
  17. Tanimoto, S.; Tominaga, H.; Okada, Y.; Nomura, M. Synthesis and cosmetic whitening effect of glycosides derived from several phenylpropanoids. Yakugaku. Zasshi. 2006, 126, 173–177. [Google Scholar] [CrossRef] [Green Version]
  18. Arakawa, M.; Someno, T.; Kawada, M.; Ikeda, D. A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis. J. Antibiot. 2008, 61, 442–448. [Google Scholar] [CrossRef] [Green Version]
  19. Wang, C.Y.; Wang, B.G.; Brauers, G.; Guan, H.S.; Proksch, P.; Ebel, R. Microsphaerones A and B, two novel gamma-pyrone derivatives from the sponge-derived fungus Microsphaeropsis sp. J. Nat. Prod. 2002, 65, 772–775. [Google Scholar] [CrossRef]
  20. You, J.; Yang, S.Z.; Mu, B.Z. Structural characterization of lipopeptides from Enterobacter sp strain N18 reveals production of surfactin homologues. Eur. J. Lipid Sci. Technol. 2015, 117, 890–898. [Google Scholar] [CrossRef]
  21. Nagia, M.M.; El-Metwally, M.M.; Shaaban, M.; El-Zalabani, S.M.; Hanna, A.G. Four butyrolactones and diverse bioactive secondary metabolites from terrestrial Aspergillus flavipes MM2: Isolation and structure determination. Org. Med. Chem. Lett. 2012, 2, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Zhang, Y.Y.; Zhang, Y.; Yao, Y.B.; Lei, X.L.; Qian, Z.J. Butyrolactone-I from coral-derived fungus Aspergillus terreus attenuates neuro-inflammatory response via suppression of NF-kappaB Pathway in BV-2 Cells. Mar. Drugs 2018, 16, 202. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. da Rocha, M.W.; Resck, I.S.; Caldas, E.D. Purification and full characterisation of citreoviridin produced by Penicillium citreonigrum in yeast extract sucrose (YES) medium. Food Addit. Contam. Part A 2015, 32, 584–595. [Google Scholar] [CrossRef] [PubMed]
  24. Xu, K.; Li, G.; Zhu, R.; Xie, F.; Li, Y.; Yang, W.; Xu, L.; Shen, T.; Zhao, Z.; Lou, H. Polyketides from the endolichenic fungus Eupenicillium javanicum and their anti-inflammatory activities. Phytochemistry 2020, 170, 112191. [Google Scholar] [CrossRef]
  25. Li, J.; Wang, J.; Jiang, C.S.; Li, G.; Guo, Y.W. (+)-Cyclopenol, a new naturally occurring 7-membered 2,5-dioxopiperazine alkaloid from the fungus Penicillium sclerotiorum endogenous with the Chinese mangrove Bruguiera gymnorrhiza. J. Asian Nat. Prod. Res. 2014, 16, 542–548. [Google Scholar] [CrossRef]
  26. Campos, P.E.; Pichon, E.; Moriou, C.; Clerc, P.; Trepos, R.; Frederich, M.; De Voogd, N.; Hellio, C.; Gauvin-Bialecki, A.; Al-Mourabit, A. New antimalarial and antimicrobial tryptamine derivatives from the marine sponge Fascaplysinopsis reticulata. Mar. Drugs 2019, 17, 167. [Google Scholar] [CrossRef] [Green Version]
  27. Wang, X.Y.; Liu, Y.Z.; Xu, J.; Jiang, F.W.; Kang, C.M. Synthesis of novel indole-benzimidazole derivatives. J. Chem. Res. 2016, 40, 588–590. [Google Scholar] [CrossRef]
  28. Hashida, J.; Niitsuma, M.; Iwatsuki, M.; Mori, M.; Ishiyama, A.; Namatame, M.; Nishihara-Tsukashima, A.; Nonaka, K.; Ui, H.; Masuma, R.; et al. Pyrenocine I, a new pyrenocine analog produced by Paecilomyces sp. FKI-3573. J. Antibiot. 2010, 63, 559–561. [Google Scholar] [CrossRef] [Green Version]
  29. Nakada, T.; Sudo, S.; Kosemura, S.; Yamamura, S. Two new metabolites of hybrid strains KO 0201 and 0211 derived from Penicillium citreoviride B. IFO 6200 and 4692. Tetrahedron Lett. 1999, 40, 6831–6834. [Google Scholar] [CrossRef]
  30. Hallock, Y.F.; Clardy, J.; Kenfield, D.S.; Strobel, G. De-O-methyldiaporthin, a phytotoxin from Drechslera siccans. Phytochemistry 1988, 27, 3123–3125. [Google Scholar] [CrossRef]
  31. Yamaguchi, Y.; Masuma, R.; Kim, Y.-P.; Uchida, R.; Tomoda, H.; Omura, S. Taxonomy and secondary metabolites of Pseudobotrytis sp. FKA-25. Mycoscience 2004, 45, 9–16. [Google Scholar] [CrossRef]
  32. Chen, C.; Ye, G.; Tang, J.; Li, J.; Liu, W.; Wu, L.; Long, Y. New polyketides from mangrove endophytic fungus Penicillium sp. BJR-P2 and their anti-inflammatory activity. Mar. Drugs 2022, 20, 583. [Google Scholar] [CrossRef] [PubMed]
  33. Frelek, J.; Ikekawa, N.; Takatsuto, S.; Snatzke, G. Application of [Mo2(OAc)4] for determination of absolute configuration of brassinosteroid vic-diols by circular dichroism. Chirality 1997, 9, 578–582. [Google Scholar] [CrossRef]
  34. Frelek, J.; Klimek, A.; Ruskowska, P. Dinuclear transition metal complexes as auxiliary chromophores in chiroptical studies on bioactive compounds. Curr. Org. Chem. 2003, 7, 1081–1104. [Google Scholar] [CrossRef]
  35. Frelek, J.; Pakulski, Z.; Zamojski, A. Application of [Mo2(OAc)4] for determination of absolute configuration of pyranoid and furanoid vic-diols by circular dichroism. Tetrahedron Asymmetry 1996, 7, 1363–1372. [Google Scholar] [CrossRef]
  36. Górecki, M.; Jabłońska, E.; Kruszewska, A.; Suszczyńska, A.; Urbańczyk-Lipkowska, Z.; Gerards, M.; Morzycki, J.W.; Szczepek, W.J.; Frelek, J. Practical method for the absolute configuration assignment of tert/tert 1,2-diols using their complexes with Mo2(OAc)4. J. Org. Chem. 2007, 72, 2906–2916. [Google Scholar] [CrossRef]
  37. Hou, H.; Zhou, R.; Li, A.; Li, C.; Li, Q.; Liu, J.; Jiang, B. Citreoviridin inhibits cell proliferation and enhances apoptosis of human umbilical vein endothelial cells. Environ. Toxicol. Pharmacol. 2014, 37, 828–836. [Google Scholar] [CrossRef]
  38. Myobatake, Y.; Kamisuki, S.; Tsukuda, S.; Higashi, T.; Chinen, T.; Takemoto, K.; Hachisuka, M.; Suzuki, Y.; Takei, M.; Tsurukawa, Y.; et al. Pyrenocine A induces monopolar spindle formation and suppresses proliferation of cancer cells. Bioorg. Med. Chem. 2019, 27, 115149. [Google Scholar] [CrossRef]
  39. Buachan, P.; Namsa-Aid, M.; Sung, H.K.; Peng, C.; Sweeney, G.; Tanechpongtamb, W. Inhibitory effects of terrein on lung cancer cell metastasis and angiogenesis. Oncol. Rep. 2021, 45, 94. [Google Scholar] [CrossRef]
  40. Feng, C.; Li, D.; Chen, M.; Jiang, L.; Liu, X.; Li, Q.; Geng, C.; Sun, X.; Yang, G.; Zhang, L.; et al. Citreoviridin induces myocardial apoptosis through PPAR-gamma-mTORC2-mediated autophagic pathway and the protective effect of thiamine and selenium. Chem. Biol. Interact. 2019, 311, 108795. [Google Scholar] [CrossRef]
  41. Zou, Z.B.; Zhang, G.; Li, S.M.; He, Z.H.; Yan, Q.X.; Lin, Y.K.; Xie, C.L.; Xia, J.M.; Luo, Z.H.; Luo, L.Z.; et al. Asperochratides A-J, ten new polyketides from the deep-sea-derived Aspergillus ochraceus. Bioorg. Chem. 2020, 105, 104349. [Google Scholar] [CrossRef] [PubMed]
  42. Xiao, H.X.; Yan, Q.X.; He, Z.H.; Zou, Z.B.; Le, Q.Q.; Chen, T.T.; Cai, B.; Yang, X.W.; Luo, S.L. Total synthesis and anti-inflammatory bioactivity of (−)-majusculoic acid and its derivatives. Mar. Drugs 2021, 19, 288. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Compounds 16 from the deep-sea-derived Penicillium citreonigrum MCCC 3A0016.
Figure 1. Compounds 16 from the deep-sea-derived Penicillium citreonigrum MCCC 3A0016.
Marinedrugs 20 00736 g001
Figure 2. The key COSY (bold) and HMBC (arrows) correlations of 1.
Figure 2. The key COSY (bold) and HMBC (arrows) correlations of 1.
Marinedrugs 20 00736 g002
Figure 3. The key NOESY correlations of compounds 16.
Figure 3. The key NOESY correlations of compounds 16.
Marinedrugs 20 00736 g003
Figure 4. Calculated and experimental ECD spectra of 1 (A) and the experimental ECD spectra of 16 (B).
Figure 4. Calculated and experimental ECD spectra of 1 (A) and the experimental ECD spectra of 16 (B).
Marinedrugs 20 00736 g004
Figure 5. CD spectra and dimolybdenum tetraacetate [Mo2(OAc)4]-induced CD spectra of compounds 16.
Figure 5. CD spectra and dimolybdenum tetraacetate [Mo2(OAc)4]-induced CD spectra of compounds 16.
Marinedrugs 20 00736 g005
Scheme 1. Conformers 1A and 1B of compound 1.
Scheme 1. Conformers 1A and 1B of compound 1.
Marinedrugs 20 00736 sch001
Figure 6. Antiproliferative effects of compounds 7, 14, and 20 on HeLa tumor cells. (A) The IC50 values of tested compounds. (B) Apoptosis activity (HeLa cells were harvested after treatment with the tested compounds for 40 h; the related protein levels were analyzed by Western blot; the cleaved PARP bands indicate the apoptosis bioactivity). (C) Structures of compounds 7, 14, and 20.
Figure 6. Antiproliferative effects of compounds 7, 14, and 20 on HeLa tumor cells. (A) The IC50 values of tested compounds. (B) Apoptosis activity (HeLa cells were harvested after treatment with the tested compounds for 40 h; the related protein levels were analyzed by Western blot; the cleaved PARP bands indicate the apoptosis bioactivity). (C) Structures of compounds 7, 14, and 20.
Marinedrugs 20 00736 g006
Figure 7. Effect of 7, 14, and 20 on cell cycle progression. HELA cells were stained by propidium iodide after treatment with 7 (20 μM), 14 (20 μM), and 20 (10 μM) for 16 h.
Figure 7. Effect of 7, 14, and 20 on cell cycle progression. HELA cells were stained by propidium iodide after treatment with 7 (20 μM), 14 (20 μM), and 20 (10 μM) for 16 h.
Marinedrugs 20 00736 g007
Figure 8. mTOR Inhibition induced by 20. HeLa cells were treated with 20 (20 μM) for 12 h. The protein level of the phosphorylation of ribosomal protein S6 was used to detect the mTOR acitivity.
Figure 8. mTOR Inhibition induced by 20. HeLa cells were treated with 20 (20 μM) for 12 h. The protein level of the phosphorylation of ribosomal protein S6 was used to detect the mTOR acitivity.
Marinedrugs 20 00736 g008
Table 1. The 1H (400 MHz) NMR data of compounds 16 in CD3OD (J in Hz).
Table 1. The 1H (400 MHz) NMR data of compounds 16 in CD3OD (J in Hz).
No.123456
11.15 d (6.4) 1.17 d (6.4) 1.33 d (6.4) 1.19 d (6.4) a1.20 d (6.4) 1.19 d (6.4)
23.92 q (6.4) a4.05 q (6.4)4.27 q (6.4) a4.10 q (6.4) 4.09 q (6.4) a4.04 q (6.4) a
44.06 s3.98 s3.76 s3.63 s4.02 s3.78 s
63.60 s3.61 s3.81 s3.50 s3.63 s3.67 s
86.41 d (15.2)6.06 d (15.2)5.96 d (15.2)6.56 d (15.2)6.01 d (15.2)6.02 d (15.2)
96.51 dd (14.8, 10.8)6.42 dd (14.8, 10.8) a6.57 a6.38 dd (15.2, 10.8) 6.42 dd (15.2, 10.8) a6.41 dd (15.2, 10.8) a
106.54 dd (14.8, 10.8)6.51 dd (14.8, 10.8) a6.58 a6.61 dd (14.8, 10.8) a6.60 dd (14.8, 10.8) a6.64 dd (15.2, 10.8) a
116.47 dd (14.8, 10.8) a 6.48 dd (15.2, 10.8)6.48 a6.46 dd (14.8, 10.8) a6.48 dd (14.8, 10.8) a6.50 dd (14.8, 11.2) a
127.14 dd (14.8, 10.8)7.13 dd (15.2, 10.8)7.12 dd (14.8, 10.8)7.14 dd (14.8, 10.8)7.14 dd (14.8, 10.8)7.16 dd (15.2, 10.8)
136.49 d (15.2)6.55 d (15.2)6.60 d (14.8) a6.57 d (15.2) a6.59 d (15.2) a6.60 d (15.2) a
175.62 s5.62 s5.62 s5.62 s5.63 s5.63 s
191.29 s1.28 s1.21 s1.17 s1.18 s1.28 s
201.23 s1.25 s 1.21 s1.30 s1.27 s1.20 s
211.35 s1.30 s 1.30 s1.45 s1.29 s1.31 s
222.00 s2.00 s2.00 s2.00 s2.01 s2.01 s
OMe3.90 s3.90 s3.91 s3.91 s3.90 s3.91 s
a overlapped 1H NMR signals.
Table 2. 13C (100 MHz) NMR data of compounds 16 in CD3OD.
Table 2. 13C (100 MHz) NMR data of compounds 16 in CD3OD.
No.1 2 3 4 5 6
113.6 q13.5 q12.1 q13.5 q13.8 q13.8 q
279.2 d80.9 d81.9 d80.2 d80.0 d79.8 d
384.1 s84.5 s85.2 s86.0 s84.9 s84.3 s
474.8 d80.9 d81.7 d79.3 d79.4 d79.1 d
584.3 s84.8 s87.4 s85.1 s87.5 s87.3 s
684.1 d76.5 d85.5 d82.2 d91.0 d92.0 d
777.2 s79.8 s76.9 s79.7 s74.3 s74.3 s
8144.7 d148.5 d144.0 d143.6 d143.5 d141.9 d
9129.0 d 128.7 d129.4 d129.1 d129.5 d129.4 d
10139.7 d138.9 d138.8 d140.0 d139.1 d139.1 d
11131.7 d132.5 d132.6 d132.0 d132.5 d132.4 d
12137.3 d137.0 d137.1 d137.3 d137.1 d137.1 d
13120.0 d120.4 d120.4 d120.0 d120.4 d120.3 d
14156.0 s155.9 s155.9 s156.0 s155.9 s155.9 s
15109.6 s109.8 s109.8 s109.6 s109.8 s109.8 s
16173.2 s173.1 s173.1 s173.1 s173.1 s173.1 s
1789.0 d89.1 d89.1 d89.0 d89.1 d89.1 d
18166.4 s166.4 s166.4 s166.4 s166.4 s166.4 s
1917.5 q17.5 q13.1 q17.3 q13.2 q13.1 q
2016.6 q18.7 q14.4 q16.7 q14.6 q14.6 q
2132.2 q26.7 q26.6 q31.2 q26.2 q27.3 q
228.9 q8.9 q8.9 q8.9 q8.9 q8.9 q
OMe57.3 q57.3 q57.3 q57.3 q57.3 q57.3 q
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zou, Z.-B.; Zhang, G.; Zhou, Y.-Q.; Xie, C.-L.; Xie, M.-M.; Xu, L.; Hao, Y.-J.; Luo, L.-Z.; Zhang, X.-K.; Yang, X.-W.; et al. Chemical Constituents of the Deep-Sea-Derived Penicillium citreonigrum MCCC 3A00169 and Their Antiproliferative Effects. Mar. Drugs 2022, 20, 736. https://doi.org/10.3390/md20120736

AMA Style

Zou Z-B, Zhang G, Zhou Y-Q, Xie C-L, Xie M-M, Xu L, Hao Y-J, Luo L-Z, Zhang X-K, Yang X-W, et al. Chemical Constituents of the Deep-Sea-Derived Penicillium citreonigrum MCCC 3A00169 and Their Antiproliferative Effects. Marine Drugs. 2022; 20(12):736. https://doi.org/10.3390/md20120736

Chicago/Turabian Style

Zou, Zheng-Biao, Gang Zhang, Yu-Qi Zhou, Chun-Lan Xie, Ming-Min Xie, Lin Xu, You-Jia Hao, Lian-Zhong Luo, Xiao-Kun Zhang, Xian-Wen Yang, and et al. 2022. "Chemical Constituents of the Deep-Sea-Derived Penicillium citreonigrum MCCC 3A00169 and Their Antiproliferative Effects" Marine Drugs 20, no. 12: 736. https://doi.org/10.3390/md20120736

APA Style

Zou, Z. -B., Zhang, G., Zhou, Y. -Q., Xie, C. -L., Xie, M. -M., Xu, L., Hao, Y. -J., Luo, L. -Z., Zhang, X. -K., Yang, X. -W., & Wang, J. -S. (2022). Chemical Constituents of the Deep-Sea-Derived Penicillium citreonigrum MCCC 3A00169 and Their Antiproliferative Effects. Marine Drugs, 20(12), 736. https://doi.org/10.3390/md20120736

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop